Document Detail


Effects of intracoronary infusion of the vasoactive intestinal peptide antagonist [4Cl-D-Phe6-Leu17]VIP in the awake dog.
MedLine Citation:
PMID:  1800959     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Intracoronary infusion of [4Cl-D-Phe6-Leu17]VIP caused modest significant inhibition of the coronary vasodilation produced by intraarterial VIP, but did not significantly inhibit serotonin-induced coronary vasodilation. In addition, infusion of [4Cl-D-Phe6-Leu17]VIP did not result in significant changes in baseline coronary resistance, heart rate or left ventricular dP/dt. These findings demonstrate that [4Cl-D-Phe6-Leu17]VIP is a competitive antagonist of VIP-induced vasodilation in the canine coronary circulation, but fail to demonstrate a significant role for VIP in the regulation of resting coronary vasomotor tone, and do not support the hypothesis that VIP is a mediator of serotonin-induced coronary arteriolar dilation.
Authors:
B B Quebbemann; J Rivier; R J Bache
Related Documents :
7161879 - Deleterious effects of vasodilating agents. induction of subendocardial ischemia in dog...
1881459 - Coronary vasodilation induced by captopril and zofenoprilat: evidence for a prostagland...
638869 - Redistribution in left ventricular regional flow following acute right ventricular pres...
1965399 - Prevention of alpha-adrenergic coronary constriction by calcium-antagonists.
12107099 - Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: ...
2297849 - Effects of h1-receptor stimulation on coronary arterial diameter and coronary hemodynam...
22574539 - Comparison of rate assessment between resting heart rate and 24-hour holter monitoring ...
12848709 - Three-dimensional transesophageal echocardiographic demonstration of anatomical defects...
16945799 - Monophasic action potentials and activation recovery intervals as measures of ventricul...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Peptides     Volume:  12     ISSN:  0196-9781     ISO Abbreviation:  Peptides     Publication Date:    1991 Sep-Oct
Date Detail:
Created Date:  1992-04-21     Completed Date:  1992-04-21     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8008690     Medline TA:  Peptides     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  989-93     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Minnesota, Minneapolis 55455.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Pressure / drug effects
Coronary Circulation / drug effects*
Coronary Vessels / drug effects,  physiology*
Dogs
Female
Heart Rate / drug effects
Infusions, Intra-Arterial
Male
Muscle, Smooth, Vascular / drug effects,  physiology
Reference Values
Serotonin / administration & dosage,  pharmacology*
Vasoactive Intestinal Peptide / administration & dosage,  analogs & derivatives*,  antagonists & inhibitors,  pharmacology*
Grant Support
ID/Acronym/Agency:
HL20598/HL/NHLBI NIH HHS; HL21872/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
102805-45-8/vasoactive intestinal peptide, 4-chloro-Phe(6)-Leu(17)-; 37221-79-7/Vasoactive Intestinal Peptide; 50-67-9/Serotonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transplantation of fetal growth hormone-releasing factor-immunoreactive neurons into the ventricular...
Next Document:  Human mast cell proteases hydrolyze neurotensin, kinetensin and Leu5-enkephalin.